6th ESO Arab and Southern European Countries Masterclass in Clinical oncology

2017-06-27

6th ESO Arab and Southern European Countries Masterclass in Clinical Oncology 15-18 December 2017 in Limassol, Cyprus.

6th ESO Arab and Southern European Countries Masterclass in Clinical oncology
 
Dear Colleague,

I am writing you regarding the 6th ESO Arab and Southern European Countries Masterclass in Clinical Oncology, held under the auspices of AMAAC, on 15-18 December 2017 in Limassol, Cyprus.

I kindly ask you whether you could encourage young clinical oncologists in your country to send their application by the deadline.

Please find here below necessary information regarding the application process.


ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY (Application deadline 11th JULY 2017). SUCCESSFUL APPLICANTS ARE GRANTED FREE REGISTRATION AND ACCOMMODATION.

IDEAL COURSE CANDIDATE


   ❖  Age up to 40 years
   ❖  At least 2-3 years’ experience in clinical oncology
   ❖  Involvement in scientific activities
   ❖  Fluency in English

HOW TO APPLY

Applications may be carried out by filling in the form at
www.eso.net (or on request at aciocchini@eso.net) and providing:

   ❖  Letter describing motivation for attending
   ❖  Supporting letter from head of department or mentor
   ❖  CV with list publications (if the list of publication is not provided,
         it will be assumed that no articles have been published)
   ❖  Clinical Case


Priority will be given to suitable applicants working in the Arab speaking countries. This event also welcomes participants from Southern Europe.


TRAVEL SUPPORT

Travel support will be made available in the amount of 250 Euro, as contribution to travel expenses, to admitted participants coming from lower-middle- income countries as defined by the World Bank.

Kind regards,

Alice Ciocchini and Daniela Mengato
European School of Oncology (ESO)

www.eso.net
 
     
  Further details can be found on the flyer that can be downloaded here or on the website:
 
 
   

Cikk értékelése

Eddig 1 felhasználó értékelte a cikket.

Hozzászólások